News
Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...
Abbott has launched a new Libre smartphone app for users of its popular FreeStyle Libre continuous glucose monitors.
Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.
The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...
Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...
Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...
10d
Zacks Investment Research on MSNDexCom Shares May Rise as G7 15-Day CGM System Gets FDA ClearanceDexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the ...
Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...
The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.
Experts discuss how to evaluate and communicate the return on investment for continuous glucose monitoring (CGM) coverage to overcome cost-related barriers, explore strategies other payers could adopt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results